Evidence map›Paper›PMID 26838049›Full record

ArticleMucosal immunology2016

KLF6 contributes to myeloid cell plasticity in the pathogenesis of intestinal inflammation.

W A Goodman, S Omenetti, D Date, L Di Martino, C De Salvo, G-D Kim, S Chowdhry, G Bamias, F Cominelli, T T Pizarro and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Mucosal immunology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 59 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Cells · 2025
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Effects of Heat-Induced Oxidative Stress and Astaxanthin on theCurrent issues in molecular biology · 2024
    Article
  15. Macrophage polarization in inflammatory bowel disease.Cell communication and signaling : CCS · 2023
    Review
  16. Article
  17. Article
  18. Macrophages in immunoregulation and therapeutics.Signal transduction and targeted therapy · 2023
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

W A GoodmanDepartment of Pathology, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA.
S OmenettiDepartment of Pathology, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA.
D DateDepartment of Medicine, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA.
L Di MartinoDepartment of Medicine, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA.
C De SalvoDepartment of Pathology, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA.
G-D KimDepartment of Medicine, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA.
S ChowdhryDepartment of Medicine, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA.
G BamiasAcademic Department of Gastroenterology, Ethnikon and Kapodistriakon University of Athens and Laikon Hospital, Athens, Greece.
F CominelliDepartment of Medicine, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA.
T T PizarroDepartment of Pathology, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA.
G H MahabeleshwarDepartment of Pathology, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA.
University School · USUniversity Hospitals of Cleveland · USNational and Kapodistrian University of Athens · GR

Funding

Ubiquitination Pathways Mediating Chronic Intestinal InflammationP01DK091222 · NIDDK · CASE WESTERN RESERVE UNIVERSITY · PI COMINELLI, FABIO · 2011 to 2020
$16.5M
The Cleveland Digestive Diseases Research Core Center (DDRCC)P30DK097948 · NIDDK · CASE WESTERN RESERVE UNIVERSITY · PI Theresa Torres Pizarro · 2015 to 2026
$15.6M
MECHANISMS OF EXPERIMENTAL CROHNS DISEASER01DK055812 · NIDDK · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI COMINELLI, FABIO · 1999 to 2019
$4.9M
CYTOKINES AND INFLAMMATORY BOWEL DISEASER01DK042191 · NIDDK · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI COMINELLI, FABIO, PIZARRO, THERESA TORRES · 1995 to 2022
$4.7M
Role of IL-18 in Crohn's Disease (CD)R01DK056762 · NIDDK · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI PIZARRO, THERESA TORRES · 2000 to 2009
$2.3M
Role of KLF6 in macrophage lipid homeostasis and atherogenesisR01HL126626 · NHLBI · CASE WESTERN RESERVE UNIVERSITY · PI MAHABALESHWAR, GANAPATI HOLANAGADDE · 2015 to 2019
$2.0M
KLF2 Mediated HIF-1 Regulation and Macrophage ActivationR00HL097023 · NHLBI · CASE WESTERN RESERVE UNIVERSITY · PI MAHABALESHWAR, GANAPATI HOLANAGADDE · 2011 to 2013
$735k
Molecular mechanisms contributing to gender differences in regulatory T cell function in Crohn's disease and experimental IBDK01DK105138 · NIDDK · CASE WESTERN RESERVE UNIVERSITY · PI GOODMAN, WENDY ANN · 2015 to 2019
$567k
Role of KLF6 in myeloid cell biologyR56HL121193 · NHLBI · CASE WESTERN RESERVE UNIVERSITY · PI MAHABALESHWAR, GANAPATI HOLANAGADDE · 2014 to 2014
$396k
KLF2 Mediated HIF-1 Regulation and Macrophage ActivationK99HL097023 · NHLBI · CASE WESTERN RESERVE UNIVERSITY · PI MAHABALESHWAR, GANAPATI HOLANAGADDE · 2009 to 2010
$180k
NHLBI NIH HHS K99 HL097023NHLBI NIH HHS R00 HL097023NHLBI NIH HHS R01 HL126626NHLBI NIH HHS R56 HL121193NIDDK NIH HHS K01 DK105138NIDDK NIH HHS P01 DK091222NIDDK NIH HHS P30 DK097948NIDDK NIH HHS R01 DK042191NIDDK NIH HHS R01 DK055812NIDDK NIH HHS R01 DK056762
6 · The paper itself

Abstract

Inflammatory bowel disease (IBD) is associated with dysregulated macrophage responses, such that quiescent macrophages acquire a pro-inflammatory activation state and contribute to chronic intestinal inflammation. The transcriptional events governing macrophage activation and gene expression in the context of chronic inflammation such as IBD remain incompletely understood. Here, we identify Kruppel-like transcription factor-6 (KLF6) as a critical regulator of pathogenic myeloid cell activation in human and experimental IBD. We found that KLF6 was significantly upregulated in myeloid cells and intestinal tissue from IBD patients and experimental models of IBD, particularly in actively inflamed regions of the colon. Using complementary gain- and loss-of-function studies, we observed that KLF6 promotes pro-inflammatory gene expression through enhancement of nuclear factor κB (NFκB) signaling, while simultaneously suppressing anti-inflammatory gene expression through repression of signal transducer and activator of transcription 3 (STAT3) signaling. To study the in vivo role of myeloid KLF6, we treated myeloid-specific KLF6-knockout mice (Mac-KLF6-KO) with dextran sulfate sodium (DSS) and found that Mac-KLF6-KO mice were protected against chemically-induced colitis; this highlights the central role of myeloid KLF6 in promoting intestinal inflammation. Collectively, our results point to a novel gene regulatory program underlying pathogenic, pro-inflammatory macrophage activation in the setting of chronic intestinal inflammation.

Indexed as

AnimalsCell LineCell PlasticityColitisColitis, UlcerativeColonCrohn DiseaseDextran SulfateGene Expression RegulationHumansKruppel-Like Factor 6Kruppel-Like Transcription FactorsMacrophage ActivationMacrophagesMaleMiceDextran SulfateKlf6 protein, mouseKruppel-Like Factor 6Kruppel-Like Transcription FactorsNF-kappa BProto-Oncogene ProteinsStat3 protein, mouseSTAT3 Transcription Factor

Identifiers

PMID26838049
PMCPMC4972715
OpenAlexW2411702270

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.